Biocept (BIOC) Institutional Ownership → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free BIOC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisEarningsHeadlinesInsider TradesOwnershipSocial Media Institutional Ownership Changes (13F Filings) for Biocept (NASDAQ:BIOC)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$54.28KNumber ofInstitutional Sellers(last 12 months)0 Get BIOC Insider Trade Alerts Want to know when executives and insiders are buying or selling Biocept stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIOC Institutional Buying and Selling by Quarter Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! Biocept Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2023Anson Funds Management LP44,861$54K0.0%N/A7.604% 4/18/2022 Taylor & Morgan Wealth Management LLC23,000$53K0.0%+91.7%0.136% 2/14/2022PDT Partners LLC35,901$130K0.0%N/A0.213% 2/10/2022Bailard Inc.42,100$152K0.0%N/A0.250% 2/10/2022Acadian Asset Management LLC62,319$225K0.0%N/A0.370% 2/10/2022Globeflex Capital L P233,578$846K0.2%-27.2%1.387% Get the Latest News and Ratings for BIOC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biocept and its competitors with MarketBeat's FREE daily newsletter. 1/21/2022 Taylor & Morgan Wealth Management LLC12,000$43K0.0%N/A0.071% 11/15/2021Marshall Wace LLP104,980$421K0.0%N/A0.713% 11/15/2021GSA Capital Partners LLP92,639$371K0.0%-38.9%0.629% 11/12/2021Jump Financial LLC19,500$78K0.0%N/A0.132% 9/17/2021Virtu Financial LLC19,004$80K0.0%N/A0.129% 8/16/2021State Street Corp37,996$159K0.0%N/A0.283% 8/13/2021Geode Capital Management LLC134,851$565K0.0%+2.4%1.006% 8/13/2021Vanguard Group Inc.658,586$2.76M0.0%-1.3%4.914% 8/5/2021GSA Capital Partners LLP151,532$635K0.1%+288.1%1.131% 5/13/2021Trexquant Investment LP10,204$52K0.0%N/A0.076% 5/12/2021Geode Capital Management LLC131,728$670K0.0%+52.2%0.983% 5/10/2021GSA Capital Partners LLP39,046$199K0.0%N/A0.291% 5/3/2021Hussman Strategic Advisors Inc.72,000$366K0.1%+1,957.1%0.537% 4/27/2021Belvedere Trading LLC75,444$384K0.0%N/A0.563% 2/24/2021Virtu Financial LLC14,647$65K0.0%N/A0.109% 2/9/2021Bank of New York Mellon Corp16,243$72K0.0%N/A0.121% 11/6/2020BlackRock Inc.191,630$845K0.0%-92.3%1.431% 11/2/2020Hussman Strategic Advisors Inc.83,500$368K0.1%N/A0.623% 8/12/2020Hudson Bay Capital Management LP37,037$26K0.0%N/A0.028% (Data available from 1/1/2016 forward) BIOC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIOC shares? During the previous two years, the following institutional investors and hedge funds held shares of Biocept shares: Anson Funds Management LP ($54K).Learn more on BIOC's institutional investors. Which institutional investors have been buying Biocept stock? The following institutional investors have purchased Biocept stock in the last 24 months: Anson Funds Management LP ($44.86K). How much institutional buying is happening at Biocept? Institutional investors have bought a total of 44,861 shares in the last 24 months. This purchase volume represents approximately $54.28K in transactions. Related Companies: BXRX Institutional Ownership ATNF Institutional Ownership VRAX Institutional Ownership NEPT Institutional Ownership TCBP Institutional Ownership PRFX Institutional Ownership EVLO Institutional Ownership ACOR Institutional Ownership NBSE Institutional Ownership BJDX Institutional Ownership This page (NASDAQ:BIOC) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biocept, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.